US Clinical Laboratory Services Market Research Report Forecast to 2027

Description

US Clinical Laboratory Services Market Research Report Forecast to 2027

Market Overview

The US clinical laboratory services market is expected to be driven by the increasing prevalence of chronic diseases and growing awareness among people regarding disease management and early diagnosis. Additionally, the growing popularity of personalized medicine will provide growth opportunities for the market in the future. However, the shortage of skilled professionals might hamper market growth during the forecast period.

The US clinical laboratory services market has helped in the early diagnosis of diseases such as cancer, infection, or others can significantly increase the chances of successful treatment at an early stage. The introduction of accurate and technologically advanced products, such as companion diagnostics, biochips, and microarrays, has bolstered the demand for early disease detection. Therefore, it is one of the important public health strategies, where governments and global organizations have started numerous initiatives to generate awareness regarding early diagnosis in the country.

The US clinical laboratory services market is emerging due to the increasing prevalence of chronic diseases and growing awareness among people regarding disease management and early diagnosis. Additionally, the growing popularity of personalized medicine will provide growth opportunities for the market in the future. However, the shortage of skilled professionals might hamper the market growth during the forecast period.

Market Segmentation

The US Clinical Laboratory Services market, based on application, has been segmented into independent laboratory, reference laboratory, and hospital laboratory.

Based on type the US clinical laboratory services market is segmented into biochemistry, endocrinology, microbiology, hematology, histopathology, cytology, and genetic testing.

Major Players

The key players profiled in the US clinical laboratory services market are Laboratory Corporation of America Holdings, Mayo Medical Laboratories, Quest Diagnostics Incorporated, Eurofins Scientific, and Sonic Healthcare Limited.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

 

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 GROWING AWARENESS AMONG PEOPLE REGARDING DISEASE MANAGEMENT AND EARLY DIAGNOSIS
4.3 RESTRAINT
4.3.1 SHORTAGE OF SKILLED PROFESSIONALS
4.4 OPPORTUNITY
4.4.1 GROWING POPULARITY OF PERSONALIZED MEDICINE
4.5 VALUE CHAIN ANALYSIS
4.5.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
4.5.2 SERVICE CUSTOMIZATION
4.5.3 CUSTOMER PURCHASE SUPPORT
4.5.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
4.6 PORTER’S FIVE FORCES MODEL
4.6.1 THREAT OF NEW ENTRANTS
4.6.2 BARGAINING POWER OF SUPPLIERS
4.6.3 THREAT OF SUBSTITUTES
4.6.4 BARGAINING POWER OF BUYERS
4.6.5 INTENSITY OF RIVALRY
4.7 IMPACT OF COVID-19 ON CLINICAL LABORATORY SERVICES MARKET
4.7.1 OVERVIEW
4.7.2 IMPACT ON PRICING
4.7.3 IMPACT ON KEY PLAYERS

5 US CLINICAL LABORATORY SERVICES MARKET BY TYPE
5.1 OVERVIEW
5.2 BIOCHEMISTRY
5.3 ENDOCRINOLOGY
5.4 MICROBIOLOGY
5.5 HEMATOLOGY
5.6 HISTOPATHOLOGY
5.7 CYTOLOGY
5.8 GENETIC TESTING
5.9 OTHERS

6 US CLINICAL LABORATORY SERVICES MARKET BY APPLICATION
6.1 OVERVIEW
6.2 INDEPENDENT LABORATORY
6.3 REFERENCE LABORATORY
6.4 HOSPITAL LABORATORY

7 COMPETITIVE LANDSCAPE
7.1 OVERVIEW
7.2 COMPETITIVE BENCHMARKING
7.3 MAJOR GROWTH STRATEGY IN THE US CLINICAL LABORATORY SERVICES MARKET
7.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE US CLINICAL LABORATORY SERVICES MARKET
7.5 KEY DEVELOPMENT ANALYSIS
7.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
7.6.1 SERVICE LAUNCHES
7.6.2 PARTNERSHIPS/ACQUISITIONS/COLLABORATIONS
7.6.3 EXPANSIONS/AGREEMENTS
7.7 FINANCIAL MATRIX
7.7.1 SALES (USD MILLION), 2020
7.7.2 R&D EXPENDITURE (USD MILLION), 2020

8 COMPANY PROFILE
8.1 MAYO MEDICAL LABORATORIES
8.1.1 COMPANY OVERVIEW
8.1.2 FINANCIAL OVERVIEW
8.1.3 SERVICES OFFERED
8.1.4 KEY DEVELOPMENTS
8.1.5 SWOT ANALYSIS
8.1.6 KEY STRATEGIES
8.2 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
8.2.1 COMPANY OVERVIEW
8.2.2 FINANCIAL OVERVIEW
8.2.3 SERVICES OFFERED
8.2.4 KEY DEVELOPMENTS
8.2.5 SWOT ANALYSIS
8.2.6 KEY STRATEGIES
8.3 QUEST DIAGNOSTICS INCORPORATED
8.3.1 COMPANY OVERVIEW
8.3.2 FINANCIAL OVERVIEW
8.3.3 SERVICES OFFERED
8.3.4 KEY DEVELOPMENTS
8.3.5 SWOT ANALYSIS
8.3.6 KEY STRATEGIES
8.4 SPECTRA LABORATORIES INC.
8.4.1 COMPANY OVERVIEW
8.4.2 FINANCIAL OVERVIEW
8.4.3 SERVICES OFFERED
8.4.4 KEY DEVELOPMENTS
8.4.5 KEY STRATEGIES
8.5 EUROFINS SCIENTIFIC
8.5.1 COMPANY OVERVIEW
8.5.2 FINANCIAL OVERVIEW
8.5.3 SERVICES OFFERED
8.5.4 KEY DEVELOPMENTS
8.5.5 SWOT ANALYSIS
8.5.6 KEY STRATEGIES
8.6 SONIC HEALTHCARE LIMITED
8.6.1 COMPANY OVERVIEW
8.6.2 FINANCIAL OVERVIEW
8.6.3 PRODUCTS/SERVICES OFFERED
8.6.4 KEY DEVELOPMENTS
8.6.5 SWOT ANALYSIS
8.6.6 KEY STRATEGIES
8.7 NEOGENOMICS LABORATORIES, INC.
8.7.1 COMPANY OVERVIEW
8.7.2 1.2.2 FINANCIAL OVERVIEW
8.7.3 PRODUCTS/SERVICES OFFERED
8.7.4 KEY DEVELOPMENTS
8.7.5 1.2.6 KEY STRATEGIES
8.8 FRESENIUS MEDICAL CARE AG & CO. KGAA
8.8.1 COMPANY OVERVIEWS
8.8.2 1.2.2 FINANCIAL OVERVIEW
8.8.3 PRODUCTS/SERVICES OFFERED
8.8.4 1.2.4 KEY DEVELOPMENTS
8.8.5 KEY STRATEGIES
8.9 CLINICAL REFERENCE LABORATORY
8.9.1 COMPANY OVERVIEW
8.9.2 FINANCIAL OVERVIEW
8.9.3 PRODUCTS/SERVICES OFFERED
8.9.4 KEY DEVELOPMENTS
8.9.5 KEY STRATEGIES
8.10 OPKO HEALTH, INC. (BIOREFERENCE LABORATORIES)
8.10.1 COMPANY OVERVIEW
8.10.2 FINANCIAL OVERVIEW
8.10.3 PRODUCTS/SERVICES OFFERED
8.10.4 1.2.4 KEY DEVELOPMENTS
8.10.5 KEY STRATEGIES

9 APPENDIX
9.1 REFERENCES
9.2 RELATED REPORTS